Related Experiment Video

Updated: Jun 21, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer

Melissa Crawford1, Kara Batte, Lianbo Yu

  • 1Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, DHLRI, 473 West 12th Avenue, Room 201, Columbus, OH 43210, USA.

Biochemical and Biophysical Research Communications
|August 6, 2009
PubMed

Insights

This study reveals that microRNA-133B (miR-133B) is significantly downregulated in lung tumors. Restoring miR-133b levels induces apoptosis in lung cancer cells, suggesting a new therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Lung cancer is a leading cause of cancer mortality.
  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
  • Aberrant miRNA expression is implicated in various cancers, including lung cancer.

Purpose of the Study:

  • To investigate the role of specific microRNAs in lung cancer pathogenesis.
  • To identify novel molecular targets for lung cancer therapy.

Main Methods:

  • Differential expression analysis of 41 miRNAs in lung tumor versus adjacent non-tumor tissue.
  • Bioinformatic prediction and experimental validation of miR-133b targets.
  • Overexpression of miR-133b in lung adenocarcinoma cell lines (H2009).
  • Assessment of apoptosis induction following gemcitabine treatment.

Main Results:

  • A significant 28-fold reduction in miR-133b expression was observed in lung tumor tissues.
  • MCL-1 and BCL2L2 (BCLw), pro-survival BCL-2 family members, were identified as direct targets of miR-133b.
  • Overexpression of miR-133b led to decreased MCL-1 and BCL2L2 levels in H2009 cells.
  • Restored miR-133b expression enhanced gemcitabine-induced apoptosis in lung cancer cells.

Conclusions:

  • Decreased miR-133b expression is a novel finding in lung cancer.
  • miR-133b functionally targets pro-survival BCL-2 family members, MCL-1 and BCL2L2.
  • miR-133b represents a potential therapeutic agent for enhancing lung cancer treatment efficacy.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...